COVID-19 Resource Center

COVID-19 Resource Center

Disclosures: The authors report no relevant financial disclosures.
January 28, 2021
1 min read

In Wuhan, 76% of COVID-19 patients report symptoms 6 months later

Disclosures: The authors report no relevant financial disclosures.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Approximately 76% of patients with COVID-19 in Wuhan, China, still experienced at least one symptom after 6 months, according to a study published recently in The Lancet.

“These results support that those with severe disease need postdischarge care,” Chaolin Huang, MD, from Jin Yin-tan Hospital, and colleagues wrote. “Longer follow-up studies in a larger population are necessary to understand the full spectrum of health consequences from COVID-19.”

Source: Huang C, et al. Lancet. 2020;doi:10.1016/S0140-6736(20)32656-8.

Previously published research showed that approximately 90% of recovered COVID-19 patients continued to report persistent symptoms after an average of 60 days.

In their study, Huang and colleagues examined 1,733 patients with COVID-19 who were discharged from Jin Yin-tan Hospital in Wuhan, where the pandemic originated. They included only patients discharged between Jan. 7, 2020, and May 29, 2020. The researchers conducted follow-up visits between June 16, 2020, and Sept. 3, 2020. The median time to follow-up was 186 days.

The researchers interviewed patients with questionnaires to determine their quality of life and symptoms. Patients also had lab tests, physical examination and a 6-minute walking test to measure endurance.

Out of 1,655 participants with data, 1,265 (76%) reported at least one symptom at follow-up, including more women than men. Within the patient groups, the most common persistent symptoms were fatigue or muscle weakness (63%), with 26% of patients having difficulty sleeping and 23% reporting anxiety or depression. Additionally, neutralizing antibody levels declined by 52.5% after 6 months in 94 patients who had their immune response measured at the peak of their infection, which the researchers wrote may raise concerns about reinfection. The patients were a median age of 57 years (interquartile range = 47), and 52% of patients were men.

“The decline of neutralizing antibodies raises concern for SARS-CoV-2 reinfection,” Huang said. “The risk of reinfection should be monitored for patients who present with new symptoms of COVID-19.”